Last reviewed · How we verify
KETAMINE
KETAMINE is a drug. It is currently FDA-approved (first approved 1970).
At a glance
| Generic name | KETAMINE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1970 |
Approved indications
Common side effects
- Anaphylaxis
- Hypotension
- Bradycardia
- Arrhythmia
- Seizures
- Laryngospasm
- Airway obstruction
- Diplopia
- Nystagmus
- Anorexia
- Nausea
- Vomiting
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine (PHASE3)
- Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Effects of Local Ketamine in Orthognathic Procedures (NA)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Neurobiology of Suicide (PHASE2)
- Randomized Trial of Sedative Choice for Intubation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KETAMINE CI brief — competitive landscape report
- KETAMINE updates RSS · CI watch RSS
Frequently asked questions about KETAMINE
What is KETAMINE?
KETAMINE is a Small molecule drug.
When was KETAMINE approved?
KETAMINE was first approved on 1970.
What development phase is KETAMINE in?
KETAMINE is FDA-approved (marketed).
What are the side effects of KETAMINE?
Common side effects of KETAMINE include Anaphylaxis, Hypotension, Bradycardia, Arrhythmia, Seizures, Laryngospasm.
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing